BURNABY, B.C. – BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $3.3 million in its first quarter.
The Burnaby, British Columbia-based company said it had a loss of 23 cents per share.
The gene therapy biotech company posted revenue of $601,000 in the period.
Xenon Pharmaceuticals shares have declined 17 per cent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.67, a fall of 51 per cent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at http://www.zacks.com/ap/XENE
Keywords: Xenon Pharmaceuticals, Earnings Report